976
Participants
Start Date
September 12, 2018
Primary Completion Date
June 21, 2021
Study Completion Date
October 12, 2033
Pembrolizumab
Administered as an intravenous (IV) infusion every 3 weeks (Q3W)
Placebo
Administered as an IV infusion every 3 weeks (Q3W)
Institut Jules Bordet ( Site 0254), Brussels
Centre Hospitalier Universitaire Vaudois ( Site 0553), Lausanne
Cliniques Universitaires Saint-Luc ( Site 0251), Brussels
Hopitaux Universitaires de Geneve HUG ( Site 0556), Geneva
Hopital du Valais ( Site 0558), Sion
Melanoma Institute Australia ( Site 0856), North Sydney
Westmead Hospital ( Site 0853), Westmead
Sandton Oncology Medical Group PTY LTD ( Site 0801), Johannesburg
Charlotte Maxeke Johannesburg Academic Hospital ( Site 0811), Parktown
GZA Sint Augustinus ( Site 0259), Wilrijk - Antwerpen
UZ Leuven ( Site 0252), Leuven
The Alfred Hospital ( Site 0852), Melbourne
Universitaetsspital Bern ( Site 0552), Bern
Jessa Ziekenhuis Campus Virga Jesse ( Site 0256), Hasselt
Universitaetsspital Basel ( Site 0554), Basel
Princess Alexandra Hospital ( Site 0857), Woolloongabba
Tasman Oncology Research Pty Ltd ( Site 0858), Southport
Cairns Base Hospital ( Site 0859), Cairns
Royal Adelaide Hospital ( Site 0861), Adelaide
Ashford Cancer Centre Research ( Site 0860), Kurralta Park
Cancer Care Langenhoven Drive Oncology Centre ( Site 0812), Port Elizabeth
Fiona Stanley Hospital ( Site 0851), Murdoch
Oncological Institute of Southern Switzerland ( Site 0557), Bellinzona
Kantonsspital Graubuenden ( Site 0555), Chur
Cape Town Oncology Trials Pty Ltd ( Site 0807), Kraaifontein
Cancercare ( Site 0810), Cape Town
Universitaetsspital Zuerich ( Site 0551), Zurich
UZ Gent ( Site 0255), Ghent
Kantonsspital St. Gallen ( Site 0559), Sankt Gallen
Laura and Isaac Perlmutter Cancer Center ( Site 0137), New York
Memorial Sloan Kettering Cancer Center ( Site 0142), New York
Mount Sinai Medical Center ( Site 0038), New York
Memorial Sloan Kettering ( Site 0006), Harrison
Hopital La Timone ( Site 0302), Marseille
University of Rochester ( Site 0019), Rochester
Children's Hospital of Pittsburgh UPMC ( Site 0144), Pittsburgh
UPMC Hillman Cancer Centers ( Site 0043), Pittsburgh
IRCCS A.O.U. San Martino - IST ( Site 0404), Genova
Onkologikoa - Instituto Oncologico de San Sebastian ( Site 0457), Donostia / San Sebastian
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0408), Milan
Universitaetsklinikum Hamburg Eppendorf (UKE) ( Site 0352), Hamburg
CHU Dijon Bourgogne ( Site 0320), Dijon
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0047), Baltimore
Elbe Klinikum Buxtehude ( Site 0354), Buxtehude
Inova Schar Cancer Institute ( Site 0014), Fairfax
VCU Massey Cancer Center ( Site 0008), Richmond
Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 0359), Kiel
ASST Papa Giovanni XXIII ( Site 0402), Bergamo
Hospital General Universitario Gregorio Maranon ( Site 0454), Madrid
Northside Hospital ( Site 0115), Atlanta
Medizinische Hochschule Hannover ( Site 0358), Hanover
Institut Claudius Regaud IUCT Oncopole ( Site 0306), Toulouse
Mayo Clinic Florida ( Site 0024), Jacksonville
CHU de Bordeaux- Hopital Saint Andre ( Site 0304), Bordeaux
Moffitt McKinley Outpatient Center ( Site 0131), Tampa
CHU Montpellier. ( Site 0312), Montpellier
Centre Eugene Marquis ( Site 0305), Rennes
IRCCS Istituto Oncologico Veneto ( Site 0407), Padua
University of Tennessee Medical Center Knoxville ( Site 0116), Knoxville
West Cancer Center - East Campus ( Site 0022), Germantown
Hospital Universitario Virgen Macarena ( Site 0455), Seville
Klinik und Poliklinik fuer Dermatologie Venerologie und Allergologie ( Site 0361), Essen
The Lindner Center for Research and Education at The Christ Hospital ( Site 0004), Cincinnati
Hospital General Universitario de Valencia ( Site 0451), Valencia
Istituto Scientifico Romagnolo per Studio e Cura Tumori IRST ( Site 0403), Meldola
Karmanos Cancer Institute ( Site 0111), Detroit
CHU Angers ( Site 0321), Angers
CHU de Reims ( Site 0307), Reims
University of Iowa Hospital and Clinics ( Site 0001), Iowa City
Azienda Ospedaliero Universitaria Senese ( Site 0401), Siena
University of Wisconsin Hospital and Clinics ( Site 0030), Madison
Mayo Clinic [Rochester, MN] ( Site 0016), Rochester
CHRU Lille - Hopital Claude Huriez ( Site 0301), Lille
Advocate Medical Group-Park Ridge ( Site 0025), Park Ridge
Northwestern Medical Group ( Site 0135), Chicago
The University of Chicago Medical Center ( Site 0007), Chicago
Siteman Cancer Center ( Site 0143), St Louis
Universitaetsklinikum in Mannheim ( Site 0351), Mannheim
C.H.U. Lyon Sud ( Site 0303), Pierre-Bénite
IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 0406), Bari
Shamir Medical Center-Assaf Harofeh ( Site 0657), Ẕerifin
Universitaetsklinikum Tuebingen ( Site 0353), Tübingen
Stephenson Cancer Center ( Site 0042), Oklahoma City
Hopital Saint Louis ( Site 0322), Paris
University of Texas-MD Anderson Cancer Center ( Site 0134), Houston
University of Colorado Cancer Center ( Site 0027), Aurora
CHU Amiens Picardie Hopital Nord ( Site 0317), Amiens
Istituto Nazionale Tumori Fondazione Pascale ( Site 0400), Napoli
Klinikum der Ludwig-Maximilians-Universitaet Muenchen ( Site 0357), Munich
University of Arizona Cancer Center ( Site 0121), Tucson
The Angeles Clinic and Research Institute ( Site 0029), Los Angeles
UCLA Hematology & Oncology ( Site 0130), Los Angeles
John Wayne Cancer Institute ( Site 0026), Santa Monica
Klinikum Nuernberg Nord ( Site 0355), Nuremberg
UCSD Moores Cancer Center ( Site 0133), La Jolla
Hopital Ambroise Pare Boulogne ( Site 0316), Boulogne-Billancourt
Institut Gustave Roussy ( Site 0300), Villejuif
Klinikum der Universitaet in Wuerzburg ( Site 0356), Würzburg
Oregon Health & Science University ( Site 0032), Portland
Seattle Cancer Care Alliance ( Site 0044), Seattle
Centro Oncologico Antofagasta ( Site 0206), Antofagasta
HaEmek Medical Center ( Site 0655), Afula
Oncocentro ( Site 0204), Viña del Mar
Rambam Medical Center ( Site 0654), Haifa
Instituto Clinico Oncologico del Sur ( Site 0203), Temuco
Chaim Sheba Medical Center. ( Site 0652), Ramat Gan
Sourasky Medical Center ( Site 0656), Tel Aviv
Fundacion Arturo Lopez Perez FALP ( Site 0200), Santiago
Pontificia Universidad Catolica de Chile ( Site 0201), Santiago
Sociedad Medica Aren y Bachero Limitada ( Site 0207), Santiago
Soroka Medical Center ( Site 0653), Beersheba
Hadassah Ein Kerem Medical Center ( Site 0651), Jerusalem
Yale University ( Site 0035), New Haven
Winship Cancer Institute of Emory University ( Site 0046), Atlanta
Massachusetts General Hospital ( Site 0126), Boston
Beth Israel Deaconess Medical Center ( Site 0141), Boston
Dana Farber Cancer Institute ( Site 0124), Boston
Hospital Erasto Gaertner ( Site 0159), Curitiba
Hospital de Caridade de Ijui ( Site 0156), Ijuí
Hospital Sao Vicente de Paulo ( Site 0158), Passo Fundo
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0154), Porto Alegre
Fundacao Pio XII - Hospital de Cancer de Barretos ( Site 0155), Barretos
Hospital de Clinicas de Rio Preto ( Site 0162), Sao Jose Do Rio Preto - SP
Instituto Nacional do Cancer II ( Site 0160), Rio de Janeiro
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0151), São Paulo
Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 0161), São Paulo
A.C. Camargo Cancer Center ( Site 0164), São Paulo
Cross Cancer Institute ( Site 0057), Edmonton
CancerCare Manitoba ( Site 0053), Winnipeg
Moncton Hospital - Horizon Health Network ( Site 0055), Moncton
The Ottawa Hospital ( Site 0058), Ottawa
Sunnybrook Research Institute ( Site 0060), Toronto
Princess Margaret Cancer Centre ( Site 0059), Toronto
Hopital Maisonneuve Rosemont ( Site 0056), Montreal
Jewish General Hospital ( Site 0054), Montreal
McGill University Health Centre ( Site 0062), Montreal
CHU de Quebec - Hotel-Dieu de Quebec ( Site 0061), Québec
SRH Wald-Klinikum Gera GmbH ( Site 0360), Gera
IDI - Istituto Dermopatico dell'Immacolata ( Site 0405), Roma
National Cancer Center Hospital ( Site 0910), Tokyo
Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 0753), Poznan
Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0769), Bydgoszcz
Pratia MCM Krakow ( Site 0773), Krakow
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 0751), Warsaw
Instytut Pomnik Centrum Zdrowia Dziecka ( Site 0759), Warsaw
Kliniczny Szpital Wojewodzki Nr 1 ( Site 0758), Rzeszów
Uniwersyteckie Centrum Kliniczne ( Site 0770), Gdansk
Beskidzkie Centrum Onkologii im. Jana Pawla II ( Site 0754), Bielsko-Biala
Uniwersyteckie Centrum Kliniczne Slaskiego Uniwersytetu Medycznego ( Site 0757), Katowice
LIFTMED ( Site 0765), Rybnik
Wilgers Oncology Centre ( Site 0806), Pretoria
MPOC ( Site 0803), Pretoria
Hospital General Universitari Vall d Hebron ( Site 0456), Barcelona
Hospital Clinic de Barcelona ( Site 0452), Barcelona
Addenbrooke's Hospital in Cambridge ( Site 0600), Cambridge
Guy s & St Thomas NHS Foundation Trust ( Site 0601), London
Royal Marsden Hospital - Fulham Road London ( Site 0613), London
The Royal Marsden NHS Foundation Trust. ( Site 0612), Sutton
Christie NHS Foundation Trust ( Site 0604), Manchester
Merck Sharp & Dohme LLC
INDUSTRY